Happy holiday season, campers! What’s up with the Real Money Portfolio as we head into a slow Thanksgiving week? The most brutal takedown of the week was NVIDIA (NVDA), which I’m sure many of you noticed this morning — that’s a stock that hit a stop loss a while back for us (I was watching […]
Articles
- Most Relevant
- Most Recent
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers are seemingly in desperate straits as they have to keep […]
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers are seemingly in desperate straits as they have to keep […]
How about that bitcoin, eh? Those of you who’ve been following my personal portfolio and reading these Friday Files closely know that I sold pretty much all of my cryptocurrencies back in September, when it got to be a large enough position that I found the cash more valuable. Lots of you think I’m crazy […]
Before I get started with the focus of today’s Friday File, a green energy stock, I wanted to give you a quick bonus idea: You might have noticed that I wrote about Matt Badiali’s teasting of Denbury Resources yesterday, the oil stock that’s using CO2 injection to boost production, but he also teased a couple […]
I’ve got a couple things to look at for you today as we close out our last working week of the year (Stock Gumshoe will be closed until after the new year, though we’ll probably have a couple quick articles for you next week). The first is a look at a Casey teaser that a […]
So… what’s going in in the Real Money Portfolio this week, as we close up shop and get ready for a bit of time with family and friends? I do have one buy to share with you today, I decided to pick up some shares of the stock that I wrote to you about a […]
Tweeka Tiwari’s Mega Trends, is touting the ”fact” that there is an FDA program to rush development of a vaccine for the latest (more virulent) strain of Ebola. He names three companies: BCRX NLNK TKMR Any thoughts Dr Kss?
Travis any thoughts on the recent teaser from Kent Moors and his publisher Mike Ward: 9,500 times more powerful than oil… And 100 times cheaper… This often-ignored fuel has quietly become an irreplaceable component of the global energy mix. As an advisor to 27 world governments, my colleague, Dr. Kent Moors has told us: Nearly […]
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers are seemingly in desperate straits as they have to keep […]
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap even after it recovered from recent lows below two dollars, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers […]
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap even after it recovered from recent lows below two dollars, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers […]
Natural gas has to be the least favorite commodity in the United States right now — it’s dirt cheap, local communities in some areas are harrumphing about earthquakes and water pollution in the areas where hydrofracking is producing this cheap gas, and the gas developers are seemingly in desperate straits as they have to keep […]
Any ideas about this new Elon Mush bashing stock? ”The moment I hear from you, you’ll have immediate access to our special report, ”Nano-Dots, Mega-Profits: Banking Up to 4,600% from Tesla’s Demise,” featuring the $0.15 tech company with exclusive rights to this tech.” what else you can expect by joining The Cutting Edge… 52 Weekly […]
I’m full into “Annual Review” mode now, when I make sure to take a good hard look at each holding in my portfolio — some of my positions are very long-term oriented and don’t often come to mind except as thoughts of, “yes I’ll probably still hold this one pretty much forever” wash through my […]
[Ed. note: Here is the next exciting installment from Jim Skelton, the Blind Squirrel, who is sharing his experiences as a financial advisor with us. As with all of our contributors, the opinions he expresses are his own, and we haven’t reviewed, approved or screened his ideas. His previous articles can be seen here.] Greetings […]
We saw a big recovery over the past week or so from those cyclical stocks that were hurt by coronavirus, as the excitement about reopening and vaccine development sends people out of direct beneficiaries of the outbreak like Teladoc (TDOC) and the stuck-at-home names and into the stocks that were most hurt by the shutdown. […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]
This counts as a “holy crap!” week when it comes to earnings, not because of any huge reporting that moved the market but because of the surge by just one stock, our fad retailer Five Below (FIVE) after earnings on Wednesday night. FIVE is generally lumped into the “dollar store” category, it’s the teen-focused retailer […]
I feel like I’m waggling back and forth on a strange tightrope, as I’ve been doing for about a year and a half now, and I sum it up kinda like this: I’m quite nervous about the valuations of the overall market and about the massive debt load for both governments and individuals in the […]
It’s been a few months since I last wrote about a teaser pitch from the Palm Beach Letter, the “entry level” letter from Common Sense Investing that was started in the last year or so by ex-Stansberry pundit Tom Dyson and marketing guru Michael Masterson/Mark Ford. (Yes, I say “entry level” even though this is […]
“When this controversial law takes effect on October 1, 2011… folks who act now could get ‘hedge fund rich’” That’s how Zachary Scheidt is launching his new service, called Hedge Fund Strategist from Taipan, a publisher in the Baltimore Agora-plex (Taipan is currently in the process of renaming itself “Insiders Strategy Group,” just to keep […]
The latest teaser from Keith Schaefer for his Oil and Gas Investments Bulletin has spurred quite a bit of chatter among Gumshoe readers, including questions from Irregulars and some speculation about possible matches … … so I thought it was high time to put the Thinkolator to work sniffing out this water-related oil services stock. […]
Marc Lichtenfeld, who we’ve covered a number of times in this space, focuses largely on biotech investments — he’s teased a number of them for a variety of different newsletters that he has helmed or contributed to, but it looks like he’s now launching a new letter from the Oxford Club called FirstLine Investor Alert. […]
I generally don’t like to write about super-heavily-hyped microcap stocks for the whole Gumshoe readership, because we’re almost guaranteed to cause a spike in the price for that stock. So when I saw the latest teaser for the Phase 1 folks over at Stansberry, and those teasers always cause a huge flood of emails to […]
Everyone loves a bit of “what you should do next year” advice at this time of the year — the magazines are full of it, the newspapers issue predictions, and all the newsletter folks swirl their tea leaves around and proclaim that it’s going to be “The Year of X!” No, not X as in […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This month I have one particular stock in mind for your consideration that I think is in a great secular growth industry, with fair valuation, a decent and growing dividend, and an appealing future. But first, a few other little things: One, don’t forget to take your taxable losses — I’m no fan of trading […]
This particular ad, or one very much like it with a few edits, has been running for about six weeks — it’s a pitch to get you to subscribe to Global Investment Strategist from Yiannis Mostrous ($497, thanks very much), and it’s all about a key Apple (AAPL) supplier. Which has been a hot investing […]
As the market tumbles thanks to the failure of the Super Committee and the rising level of feelings of impending doom, I picked up a few more shares of Apple this morning when they triggered a buy limit order down here in the $370 neighborhood. I have no idea whether or not this will be […]
I personally picked up some additional shares of Sprott Resource Lending this week, I had put in a bid at $1.38 a little while ago in hopes that the stock would dip a bit for me, and that bid triggered today. My opinion on SILU hasn’t changed over the last nearly a year since I […]
I personally picked up some additional shares of Sprott Resource Lending this week, I had put in a bid at $1.38 a little while ago in hopes that the stock would dip a bit for me, and that bid triggered today. My opinion on SILU hasn’t changed over the last nearly a year since I […]